Group 1 - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for 13 companies, including Mandii International, regarding compliance issues related to offshore structures and reverse mergers [1][2] - Mandii International has submitted its application to the Hong Kong Stock Exchange for a main board listing, with Huatai International as its exclusive sponsor [1] - Mandii International is a leading professional consumer pharmaceutical company in China, focusing on comprehensive and long-term solutions for skin health and weight management, particularly in the hair health sector [3] Group 2 - Mandii International's flagship product, the Mandii series minoxidil hair loss treatment, has ranked first in the Chinese hair loss medication market and minoxidil drug market for ten consecutive years since 2014, with market shares of approximately 57% and 71% respectively in 2024 [3]
蔓迪国际拟港股上市 中国证监会要求补充说明离岸架构及返程并购的合规性等